Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Doxorubicin"" wg kryterium: Temat


Tytuł:
A Design-Conversed Strategy Establishes the Performance Safe Space for Doxorubicin Nanosimilars.
Autorzy:
Nagpal S; Department of Pharmacy and Pharmaceutical Sciences, Faculty of Science, National University of Singapore, 4 Science Drive 2, Singapore 117544, Singapore.
Png Yi Jie J; Department of Pharmacy and Pharmaceutical Sciences, Faculty of Science, National University of Singapore, 4 Science Drive 2, Singapore 117544, Singapore.
Malinovskaya J; Dmitry Mendeleev University of Chemical Technology of Russia, Miusskaya pl. 9, Moscow 125047, Russia.
Kovshova T; Dmitry Mendeleev University of Chemical Technology of Russia, Miusskaya pl. 9, Moscow 125047, Russia.
Jain P; Sun Pharma Advanced Research Company Ltd., 17 B Mahal Industrial Estate, Mahakali Caves Road, Andheri (East), Mumbai, Maharashtra 400093, India.; Sun Pharma Advanced Research Centre (SPARC), Tandalja, Vadodara, Gujarat 390 020, India.
Naik S; Sun Pharma Advanced Research Company Ltd., 17 B Mahal Industrial Estate, Mahakali Caves Road, Andheri (East), Mumbai, Maharashtra 400093, India.; Sun Pharma Advanced Research Centre (SPARC), Tandalja, Vadodara, Gujarat 390 020, India.
Khopade A; Sun Pharma Advanced Research Company Ltd., 17 B Mahal Industrial Estate, Mahakali Caves Road, Andheri (East), Mumbai, Maharashtra 400093, India.; Sun Pharma Advanced Research Centre (SPARC), Tandalja, Vadodara, Gujarat 390 020, India.
Bhowmick S; Sun Pharma Advanced Research Company Ltd., 17 B Mahal Industrial Estate, Mahakali Caves Road, Andheri (East), Mumbai, Maharashtra 400093, India.; Sun Pharma Advanced Research Centre (SPARC), Tandalja, Vadodara, Gujarat 390 020, India.
Shahi P; Sun Pharma Advanced Research Company Ltd., 17 B Mahal Industrial Estate, Mahakali Caves Road, Andheri (East), Mumbai, Maharashtra 400093, India.; Sun Pharma Advanced Research Centre (SPARC), Tandalja, Vadodara, Gujarat 390 020, India.
Chakra A; Sun Pharma Advanced Research Company Ltd., 17 B Mahal Industrial Estate, Mahakali Caves Road, Andheri (East), Mumbai, Maharashtra 400093, India.; Sun Pharma Advanced Research Centre (SPARC), Tandalja, Vadodara, Gujarat 390 020, India.
Bhokari A; Sun Pharma Advanced Research Company Ltd., 17 B Mahal Industrial Estate, Mahakali Caves Road, Andheri (East), Mumbai, Maharashtra 400093, India.; Sun Pharma Advanced Research Centre (SPARC), Tandalja, Vadodara, Gujarat 390 020, India.
Shah V; Sun Pharma Advanced Research Company Ltd., 17 B Mahal Industrial Estate, Mahakali Caves Road, Andheri (East), Mumbai, Maharashtra 400093, India.; Sun Pharma Advanced Research Centre (SPARC), Tandalja, Vadodara, Gujarat 390 020, India.
Gelperina S; Dmitry Mendeleev University of Chemical Technology of Russia, Miusskaya pl. 9, Moscow 125047, Russia.
Wacker MG; Department of Pharmacy and Pharmaceutical Sciences, Faculty of Science, National University of Singapore, 4 Science Drive 2, Singapore 117544, Singapore.
Pokaż więcej
Źródło:
ACS nano [ACS Nano] 2024 Feb 27; Vol. 18 (8), pp. 6162-6175. Date of Electronic Publication: 2024 Feb 15.
Typ publikacji:
Journal Article
MeSH Terms:
Doxorubicin*/*analogs & derivatives
Doxorubicin*/pharmacokinetics
Polyethylene Glycols*/pharmacokinetics
Czasopismo naukowe
Tytuł:
Chemosensitization of tumors via simultaneous delivery of STAT3 inhibitor and doxorubicin through HPMA copolymer-based nanotherapeutics with pH-sensitive activation.
Autorzy:
Kovář M; Institute of Microbiology, Czech Academy of Sciences, Vídeňská 1083, 14220 Prague, Czech Republic.
Šubr V; Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského nám. 2, 16200 Prague, Czech Republic.
Běhalová K; Institute of Microbiology, Czech Academy of Sciences, Vídeňská 1083, 14220 Prague, Czech Republic.
Studenovský M; Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského nám. 2, 16200 Prague, Czech Republic.
Starenko D; Institute of Microbiology, Czech Academy of Sciences, Vídeňská 1083, 14220 Prague, Czech Republic.
Kovářová J; Institute of Microbiology, Czech Academy of Sciences, Vídeňská 1083, 14220 Prague, Czech Republic.
Procházková P; Institute of Microbiology, Czech Academy of Sciences, Vídeňská 1083, 14220 Prague, Czech Republic.
Etrych T; Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského nám. 2, 16200 Prague, Czech Republic.
Kostka L; Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského nám. 2, 16200 Prague, Czech Republic. Electronic address: .
Pokaż więcej
Źródło:
Nanomedicine : nanotechnology, biology, and medicine [Nanomedicine] 2024 Feb; Vol. 56, pp. 102730. Date of Electronic Publication: 2023 Dec 27.
Typ publikacji:
Journal Article
MeSH Terms:
Doxorubicin*/pharmacology
Doxorubicin*/therapeutic use
Neoplasms*/drug therapy
Methacrylates*
Mice ; Humans ; Animals ; Polymethacrylic Acids ; Hydrogen-Ion Concentration ; STAT3 Transcription Factor/metabolism
Czasopismo naukowe
Tytuł:
Combination Treatment with EGFR Inhibitor and Doxorubicin Synergistically Inhibits Proliferation of MCF-7 Cells and MDA-MB-231 Triple-Negative Breast Cancer Cells In Vitro.
Autorzy:
Abrahams B; Department of Basic Medical Sciences, Faculty of Health Sciences, University of the Free State, Bloemfontein 9301, South Africa.
Gerber A; Department of Basic Medical Sciences, Faculty of Health Sciences, University of the Free State, Bloemfontein 9301, South Africa.
Hiss DC; Department of Medical Biosciences, Faculty of Natural Sciences, University of the Western Cape, Bellville 7535, South Africa.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 06; Vol. 25 (5). Date of Electronic Publication: 2024 Mar 06.
Typ publikacji:
Journal Article
MeSH Terms:
Doxorubicin*/pharmacology
ErbB Receptors*/antagonists & inhibitors
Triple Negative Breast Neoplasms*/drug therapy
Triple Negative Breast Neoplasms*/metabolism
Female ; Humans ; Apoptosis ; Cell Line, Tumor ; Cell Proliferation ; MCF-7 Cells ; Drug Synergism
Czasopismo naukowe
Tytuł:
Blood-Nanoparticle Interactions Create a Brain Delivery Superhighway for Doxorubicin.
Autorzy:
Li Z; National University of Singapore, Department of Pharmacy and Pharmaceutical Sciences, Faculty of Science, Singapore.
Kovshova T; Dmitry Mendeleev University of Chemical Technology of Russia, Moscow, Russia.
Malinovskaya J; Dmitry Mendeleev University of Chemical Technology of Russia, Moscow, Russia.
Knoll J; National University of Singapore, Department of Pharmacy and Pharmaceutical Sciences, Faculty of Science, Singapore.
Shanehsazzadeh S; National University of Singapore, Department of Pharmacy and Pharmaceutical Sciences, Faculty of Science, Singapore.
Osipova N; Dmitry Mendeleev University of Chemical Technology of Russia, Moscow, Russia.
Chernysheva A; V. Serbsky Federal Medical Research Centre of Psychiatry and Narcology of the Ministry of Health of the Russian Federation, Moscow, Russia.
Melnikov P; Dmitry Mendeleev University of Chemical Technology of Russia, Moscow, Russia.
Gelperina S; Dmitry Mendeleev University of Chemical Technology of Russia, Moscow, Russia.
Wacker MG; National University of Singapore, Department of Pharmacy and Pharmaceutical Sciences, Faculty of Science, Singapore.
Pokaż więcej
Źródło:
International journal of nanomedicine [Int J Nanomedicine] 2024 Mar 05; Vol. 19, pp. 2039-2056. Date of Electronic Publication: 2024 Mar 05 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Nanoparticles*/chemistry
Enbucrilate*/chemistry
Doxorubicin/*analogs & derivatives
Brain/metabolism ; Blood-Brain Barrier/metabolism ; Doxorubicin/metabolism ; Surface-Active Agents ; Drug Carriers/chemistry ; Polyethylene Glycols
Czasopismo naukowe
Tytuł:
METTL3/IGF2BP3-regulated m6A modification of HYOU1 confers doxorubicin resistance in breast cancer.
Autorzy:
Zhou S; Department of Thyroid and Breast Surgery, Ningbo Medical Center Lihuili Hospital, Ningbo, Zhejiang, China.
Sheng L; Gulou Street Community Health Service Center, Haishu District, Ningbo, Zhejiang, China.
Zhang L; Department of Clinical Laboratory, Ningbo Medical Center Lihuili Hospital, Ningbo, Zhejiang, China.
Zhang J; Department of Thyroid and Breast Surgery, Ningbo Medical Center Lihuili Hospital, Ningbo, Zhejiang, China.
Wang L; Department of Thyroid and Breast Surgery, Ningbo Medical Center Lihuili Hospital, Ningbo, Zhejiang, China. Electronic address: .
Pokaż więcej
Źródło:
Biochimica et biophysica acta. General subjects [Biochim Biophys Acta Gen Subj] 2024 Mar; Vol. 1868 (3), pp. 130542. Date of Electronic Publication: 2023 Dec 15.
Typ publikacji:
Journal Article
MeSH Terms:
Doxorubicin*/pharmacology
Triple Negative Breast Neoplasms*
Adenine/*analogs & derivatives
Humans ; Methyltransferases/genetics ; RNA, Messenger
Czasopismo naukowe
Tytuł:
Development of PET Radioisotope Copper-64-Labeled Theranostic Immunoliposomes for EGFR Overexpressing Cancer-Targeted Therapy and Imaging.
Autorzy:
Jeong HY; Department of Biomedical Laboratory Science, Yonsei University, Wonju 26493, Republic of Korea.; Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Republic of Korea.
Kang SJ; Department of Biomedical Laboratory Science, Yonsei University, Wonju 26493, Republic of Korea.
Kim MW; Department of Biomedical Laboratory Science, Yonsei University, Wonju 26493, Republic of Korea.
Jeong IH; Department of Biomedical Laboratory Science, Yonsei University, Wonju 26493, Republic of Korea.
Choi MJ; Department of Biomedical Laboratory Science, Yonsei University, Wonju 26493, Republic of Korea.
Jung C; Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Republic of Korea.
Song IH; Division of RI-Convergence Research, Korea Institute of Radiological and Medical Science, Seoul 01812, Republic of Korea.
Lee TS; Division of RI-Convergence Research, Korea Institute of Radiological and Medical Science, Seoul 01812, Republic of Korea.
Park YS; Department of Biomedical Laboratory Science, Yonsei University, Wonju 26493, Republic of Korea.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 02; Vol. 25 (3). Date of Electronic Publication: 2024 Feb 02.
Typ publikacji:
Journal Article
MeSH Terms:
Copper Radioisotopes*
Doxorubicin*/therapeutic use
Doxorubicin*/analogs & derivatives
Liposomes*
Neoplasms*/diagnostic imaging
Neoplasms*/drug therapy
Animals ; Humans ; Mice ; Cell Line, Tumor ; Copper ; Drug Delivery Systems/methods ; ErbB Receptors/metabolism ; Polyethylene Glycols ; Positron-Emission Tomography ; Precision Medicine
Czasopismo naukowe
Tytuł:
The effects of stiffness on the specificity and avidity of antibody-coated microcapsules with target cells are strongly shape dependent.
Autorzy:
Liu R; Tianjin Key Laboratory of Biomedical Materials, Biomedical Barriers Research Center, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300192, China.
Zhang Z; Tianjin Key Laboratory of Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmaceutical Sciences; Key Laboratory of Immune Microenvironment and Diseases (Ministry of Education), Tianjin Medical University, Tianjin 300070, China.
Liu L; Tianjin Key Laboratory of Biomedical Materials, Biomedical Barriers Research Center, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300192, China.
Li X; Tianjin Key Laboratory of Biomedical Materials, Biomedical Barriers Research Center, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300192, China.
Duan R; Tianjin Key Laboratory of Biomedical Materials, Biomedical Barriers Research Center, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300192, China.
Ren Y; Tianjin Key Laboratory of Biomedical Materials, Biomedical Barriers Research Center, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300192, China.
Du B; Tianjin Key Laboratory of Biomedical Materials, Biomedical Barriers Research Center, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300192, China. Electronic address: .
Zhang Q; Tianjin Key Laboratory of Biomedical Materials, Biomedical Barriers Research Center, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300192, China; Fujian Bote Biotechnology Co. Ltd, Fuzhou, Fujian 350013, China; Institute of Biomedical Engineering, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen 518020, Guangdong, China. Electronic address: .
Zhou Z; Tianjin Key Laboratory of Biomedical Materials, Biomedical Barriers Research Center, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300192, China.
Pokaż więcej
Źródło:
Colloids and surfaces. B, Biointerfaces [Colloids Surf B Biointerfaces] 2024 Feb; Vol. 234, pp. 113752. Date of Electronic Publication: 2024 Jan 10.
Typ publikacji:
Journal Article
MeSH Terms:
Doxorubicin*/pharmacology
Doxorubicin*/chemistry
Drug Carriers*/chemistry
Capsules/chemistry ; Trastuzumab/pharmacology ; Cell Line, Tumor
Czasopismo naukowe
Tytuł:
Cardioprotective Effects of Leucine Supplementation against Doxorubicin-Induced Cardiotoxicit.
Autorzy:
Guimarães LC; Laboratory of Experimental Medicine, Department of Health Sciences - PGCS, Faculty of Medicine, Federal University of Uberlândia, Uberlândia, Brazil. .
Fidale TM; Biotechnology Institute. Department of Medicine, Federal University of Catalão, Catalão, Goiás, Brazil.
Pereira TCR; Institute of Biomedical Sciences, Department of Physiology, Federal University of Uberlândia, Uberlândia, MG, Brazil.
Lopes PR; School of Dentistry-FOAr, Department of Physiology and Pathology, Universidade Estadual Paulista 'Júlio de Mesquita Filho'-UNESP, Araraquara, SP, Brazil.
Ferreira-Junior MD; Laboratory of Endocrine Physiology and Metabolism, ICB, Universidade Federal de Goiás, Goiânia, GO, Brazil.
Deconte SR; UFU-ICBIM. Department of Physiology and Biophysics, Federal University of Uberlândia, Uberlândia, Brazil.
Ferreira-Neto ML; UFU-ICBIM. Department of Physiology and Biophysics, Federal University of Uberlândia, Uberlândia, Brazil.
Brito WS; Federal University of Piauí, Teresina, PI, Brazil.
Gomes RM; Laboratory of Endocrine Physiology and Metabolism, ICB, Universidade Federal de Goiás, Goiânia, GO, Brazil.
de Souza FR; Laboratory of Experimental Medicine, Department of Medicine, Federal University of Uberlândia, Uberlândia, MG, Brazil.
Cavalcante KVN; Laboratory of Endocrine Physiology and Metabolism, ICB, Universidade Federal de Goiás, Goiânia, GO, Brazil.
Herrera GC; The Veterinary Hospital, Federal University of Uberlândia, Uberlândia, MG, Brazil.
de Moura FBR; Department of Biological Sciences, Federal University of Catalão, Catalão, Goiás, Brazil.
Resende ES; Laboratory of Experimental Medicine, Department of Health Sciences - PGCS, Faculty of Medicine, Federal University of Uberlândia, Uberlândia, Brazil.; Postgraduate Program in Health Sciences-PGCS, Faculty of Medicine, Federal University of Uberlândia, Uberlândia, MG, Brazil.
Pokaż więcej
Źródło:
Cardiovascular toxicology [Cardiovasc Toxicol] 2024 Feb; Vol. 24 (2), pp. 122-132. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:
Journal Article
MeSH Terms:
Doxorubicin*/pharmacology
Cardiotoxicity*
Humans ; Rats ; Animals ; Male ; Catalase/metabolism ; Leucine/pharmacology ; Leucine/metabolism ; Leucine/therapeutic use ; Rats, Wistar ; Oxidative Stress ; Dietary Supplements
Czasopismo naukowe
Tytuł:
Thiazolobenzamide-Naphthalene Hybrids as Potent Anticancer agents compared to Doxorubicin: Design, Synthesis, SAR, In-silico and Toxicity Analysis.
Autorzy:
Kazmi MT; Department of Pharmaceutical Chemistry, School of Pharmaceutical Education & Research, Jamia Hamdard, New Delhi, 110 062, India.
Amir M; Department of Pharmaceutical Chemistry, School of Pharmaceutical Education & Research, Jamia Hamdard, New Delhi, 110 062, India.
Iqbal MA; Department of Pharmaceutical Chemistry, School of Pharmaceutical Education & Research, Jamia Hamdard, New Delhi, 110 062, India.
Rashid M; Department of Pharmacognosy and Pharmaceutical Chemistry, College of Dentistry and Pharmacy, Buraydah Private Colleges, Buraydah, 51418, Al-Qassim, Saudi Arabia.
Husain A; Department of Pharmaceutical Chemistry, School of Pharmaceutical Education & Research, Jamia Hamdard, New Delhi, 110 062, India.
Pokaż więcej
Źródło:
Chemistry & biodiversity [Chem Biodivers] 2024 Feb; Vol. 21 (2), pp. e202301662. Date of Electronic Publication: 2024 Jan 10.
Typ publikacji:
Journal Article
MeSH Terms:
Doxorubicin*/pharmacology
Antineoplastic Agents*/chemistry
Rats ; Animals ; Molecular Structure ; Structure-Activity Relationship ; Molecular Docking Simulation ; Drug Screening Assays, Antitumor ; Cell Line, Tumor ; Naphthalenes/pharmacology ; Cell Proliferation
Czasopismo naukowe
Tytuł:
Deubiquitinase OTUB1 regulates doxorubicin-induced cardiotoxicity via deubiquitinating c-MYC.
Autorzy:
Xu F; Department of Cardiology, Zhongshan Hospital, Fudan University, Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai, China; Shanghai Institute of Cardiovascular Diseases, Shanghai, China; National Clinical Research Center for Interventional Medicine & Shanghai Clinical Research Center for Interventional Medicine (19MC1910300), Shanghai, China; Department of Cardiology and Laboratory of Heart Valve Disease, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Zang T; Department of Cardiology, Zhongshan Hospital, Fudan University, Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai, China; Shanghai Institute of Cardiovascular Diseases, Shanghai, China; National Clinical Research Center for Interventional Medicine & Shanghai Clinical Research Center for Interventional Medicine (19MC1910300), Shanghai, China.
Chen H; Department of Cardiology, Zhongshan Hospital, Fudan University, Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai, China; Shanghai Institute of Cardiovascular Diseases, Shanghai, China; National Clinical Research Center for Interventional Medicine & Shanghai Clinical Research Center for Interventional Medicine (19MC1910300), Shanghai, China.
Zhou C; Department of Cardiology, Zhongshan Hospital, Fudan University, Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai, China; Shanghai Institute of Cardiovascular Diseases, Shanghai, China; National Clinical Research Center for Interventional Medicine & Shanghai Clinical Research Center for Interventional Medicine (19MC1910300), Shanghai, China.
Wang R; Department of Cardiology, Zhongshan Hospital, Fudan University, Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai, China; Shanghai Institute of Cardiovascular Diseases, Shanghai, China; National Clinical Research Center for Interventional Medicine & Shanghai Clinical Research Center for Interventional Medicine (19MC1910300), Shanghai, China.
Yu Y; Department of Cardiology, Zhongshan Hospital, Fudan University, Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai, China; Shanghai Institute of Cardiovascular Diseases, Shanghai, China; National Clinical Research Center for Interventional Medicine & Shanghai Clinical Research Center for Interventional Medicine (19MC1910300), Shanghai, China.
Shen L; Department of Cardiology, Zhongshan Hospital, Fudan University, Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai, China; Shanghai Institute of Cardiovascular Diseases, Shanghai, China; National Clinical Research Center for Interventional Medicine & Shanghai Clinical Research Center for Interventional Medicine (19MC1910300), Shanghai, China. Electronic address: .
Qian J; Department of Cardiology, Zhongshan Hospital, Fudan University, Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai, China; Shanghai Institute of Cardiovascular Diseases, Shanghai, China; National Clinical Research Center for Interventional Medicine & Shanghai Clinical Research Center for Interventional Medicine (19MC1910300), Shanghai, China. Electronic address: .
Ge J; Department of Cardiology, Zhongshan Hospital, Fudan University, Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai, China; Shanghai Institute of Cardiovascular Diseases, Shanghai, China; National Clinical Research Center for Interventional Medicine & Shanghai Clinical Research Center for Interventional Medicine (19MC1910300), Shanghai, China. Electronic address: .
Pokaż więcej
Źródło:
Cellular signalling [Cell Signal] 2024 Jan; Vol. 113, pp. 110937. Date of Electronic Publication: 2023 Oct 21.
Typ publikacji:
Journal Article
MeSH Terms:
Cardiotoxicity*/metabolism
Doxorubicin*/toxicity
Mice ; Animals ; Myocytes, Cardiac/metabolism ; Oxidative Stress ; Apoptosis ; Antioxidants/pharmacology ; Deubiquitinating Enzymes/metabolism
Czasopismo naukowe
Tytuł:
A real-world analysis of FDA Adverse Event Reporting System (FAERS) events for liposomal and conventional doxorubicins.
Autorzy:
Su H; Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Jia J; Department of Pharmacy, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
Mao Y; Medical School, Kunming University of Science and Technology, Kunming, Yunnan, China.
Zhu R; Department of Pharmacy, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
Li Z; Department of Dermatology, Qilu Hospital, Shandong University, Jinan, Shandong, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 01; Vol. 14 (1), pp. 5095. Date of Electronic Publication: 2024 Mar 01.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasms*/drug therapy
Neutropenia*/chemically induced
Pneumonia*/drug therapy
Doxorubicin/*analogs & derivatives
Humans ; Cardiotoxicity/drug therapy ; Bayes Theorem ; Doxorubicin/adverse effects ; Liposomes ; Polyethylene Glycols
Czasopismo naukowe
Tytuł:
A Microfluidic Platform for Evaluating the Internalization of Liposome Drug Carriers in Tumor Spheroids.
Autorzy:
Yakavets I; Department of Chemistry, University of Toronto, 80 St. George Street, Toronto, Ontario M5S 3H6, Canada.
Ayachit M; Department of Chemistry, University of Toronto, 80 St. George Street, Toronto, Ontario M5S 3H6, Canada.; Department of Chemistry, Queen's University, Kingston, Ontario K7L 3N6, Canada.
Kheiri S; Department of Mechanical & Industrial Engineering, University of Toronto, 5 King's College Road, Toronto, Ontario M5S 3G8, Canada.
Chen Z; Department of Chemistry, University of Toronto, 80 St. George Street, Toronto, Ontario M5S 3H6, Canada.
Rakhshani F; Department of Chemistry, University of Toronto, 80 St. George Street, Toronto, Ontario M5S 3H6, Canada.
McWhirter S; Department of Chemistry, University of Toronto, 80 St. George Street, Toronto, Ontario M5S 3H6, Canada.
Young EWK; Department of Mechanical & Industrial Engineering, University of Toronto, 5 King's College Road, Toronto, Ontario M5S 3G8, Canada.; Institute of Biomedical Engineering, University of Toronto, 164 College Street, Toronto, Ontario M5S 3G9, Canada.
Walker GC; Department of Chemistry, University of Toronto, 80 St. George Street, Toronto, Ontario M5S 3H6, Canada.
Kumacheva E; Department of Chemistry, University of Toronto, 80 St. George Street, Toronto, Ontario M5S 3H6, Canada.; Institute of Biomedical Engineering, University of Toronto, 164 College Street, Toronto, Ontario M5S 3G9, Canada.; Department of Chemical Engineering and Applied Chemistry, University of Toronto, 200 College Street, Toronto, Ontario M5S 3E5, Canada.
Pokaż więcej
Źródło:
ACS applied materials & interfaces [ACS Appl Mater Interfaces] 2024 Feb 28; Vol. 16 (8), pp. 9690-9701. Date of Electronic Publication: 2024 Feb 15.
Typ publikacji:
Journal Article
MeSH Terms:
Liposomes*/chemistry
Neoplasms*
Doxorubicin/*analogs & derivatives
Humans ; Drug Carriers/chemistry ; Microfluidics ; Spheroids, Cellular ; Doxorubicin/pharmacology ; Polyethylene Glycols
Czasopismo naukowe
Tytuł:
Efficacy of single-agent chemotherapy with pegylated liposomal doxorubicin or gemcitabine in a diverse cohort of patients with recalcitrant cutaneous T-cell lymphoma.
Autorzy:
Weiner D; Departments of Dermatology.
Ly A; Departments of Dermatology.
Talluru S; Departments of Dermatology.
Munjal A; Departments of Dermatology.
Pierog O; Departments of Dermatology.
Ambinder R; Oncology, Johns Hopkins School of Medicine, Baltimore, USA.
Rozati S; Departments of Dermatology.
Pokaż więcej
Źródło:
The British journal of dermatology [Br J Dermatol] 2024 Feb 16; Vol. 190 (3), pp. 436-438.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphoma, T-Cell, Cutaneous*/drug therapy
Skin Neoplasms*/drug therapy
Doxorubicin/*analogs & derivatives
Humans ; Gemcitabine ; Doxorubicin/therapeutic use ; Polyethylene Glycols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Czasopismo naukowe
Tytuł:
Anticancer Drug Extraction from Plasma Samples Using Three-Dimensional Polyoxometalate-Based Supramolecular Frameworks as Sorbents.
Autorzy:
Khoshkhan Z; Department of Chemistry, Faculty of Science, Ferdowsi University of Mashhad, 9177948974 Mashhad, Iran.
Mirzaei M; Department of Chemistry, Faculty of Science, Ferdowsi University of Mashhad, 9177948974 Mashhad, Iran.
Amiri A; Department of Chemistry, Faculty of Science, Ferdowsi University of Mashhad, 9177948974 Mashhad, Iran.
Lotfian N; Department of Chemistry, Faculty of Science, Ferdowsi University of Mashhad, 9177948974 Mashhad, Iran.
Mague JT; Department of Chemistry, Tulane University, New Orleans, Louisiana 70118, United States.
Pokaż więcej
Źródło:
Inorganic chemistry [Inorg Chem] 2024 Feb 12; Vol. 63 (6), pp. 2877-2887. Date of Electronic Publication: 2024 Jan 29.
Typ publikacji:
Journal Article
MeSH Terms:
Polymers*
Doxorubicin*
Polyelectrolytes*
Humans ; Epirubicin ; Anions
Czasopismo naukowe
Tytuł:
Enhanced Sensitivity of A549 Cells to Doxorubicin with WS 2 and WSe 2 Nanosheets via the Induction of Autophagy.
Autorzy:
Jin W; College of Science & Technology, Hebei Agricultural University, Huanghua 061100, China.
Yang T; College of Science & Technology, Hebei Agricultural University, Huanghua 061100, China.
Jia J; College of Science & Technology, Hebei Agricultural University, Huanghua 061100, China.
Jia J; Institute of Environmental Research at Greater Bay Area, Key Laboratory for Water Quality and Conservation of the Pearl River Delta, Ministry of Education, Guangzhou University, Guangzhou 510006, China.
Zhou X; College of Science & Technology, Hebei Agricultural University, Huanghua 061100, China.; Hebei Key Laboratory of Analysis and Control of Zoonotic Pathogenic Microorganism, Baoding 071000, China.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 18; Vol. 25 (2). Date of Electronic Publication: 2024 Jan 18.
Typ publikacji:
Journal Article
MeSH Terms:
Doxorubicin*/pharmacology
Lung Neoplasms*
Humans ; Animals ; Mice ; A549 Cells ; Autophagy ; Epithelial Cells
Czasopismo naukowe
Tytuł:
A pro-death autophagy-based nanoplatform for enhancing antitumour efficacy with improved immune responses.
Autorzy:
Li Y; NMPA Key Laboratory for Technology Research and Evaluation of Drug Products and Key Laboratory of Chemical Biology (Ministry of Education), Department of Pharmaceutics, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, PR China.
Du X; Department of Pharmacy, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250033, PR China. Electronic address: .
Kong X; NMPA Key Laboratory for Technology Research and Evaluation of Drug Products and Key Laboratory of Chemical Biology (Ministry of Education), Department of Pharmaceutics, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, PR China.
Fang Y; NMPA Key Laboratory for Technology Research and Evaluation of Drug Products and Key Laboratory of Chemical Biology (Ministry of Education), Department of Pharmaceutics, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, PR China.
He Z; NMPA Key Laboratory for Technology Research and Evaluation of Drug Products and Key Laboratory of Chemical Biology (Ministry of Education), Department of Pharmaceutics, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, PR China.
Liu D; NMPA Key Laboratory for Technology Research and Evaluation of Drug Products and Key Laboratory of Chemical Biology (Ministry of Education), Department of Pharmaceutics, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, PR China.
Wu H; NMPA Key Laboratory for Technology Research and Evaluation of Drug Products and Key Laboratory of Chemical Biology (Ministry of Education), Department of Pharmaceutics, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, PR China.
Ji J; NMPA Key Laboratory for Technology Research and Evaluation of Drug Products and Key Laboratory of Chemical Biology (Ministry of Education), Department of Pharmaceutics, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, PR China.
Yang X; NMPA Key Laboratory for Technology Research and Evaluation of Drug Products and Key Laboratory of Chemical Biology (Ministry of Education), Department of Pharmaceutics, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, PR China.
Ye L; NMPA Key Laboratory for Technology Research and Evaluation of Drug Products and Key Laboratory of Chemical Biology (Ministry of Education), Department of Pharmaceutics, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, PR China.
Zhai G; NMPA Key Laboratory for Technology Research and Evaluation of Drug Products and Key Laboratory of Chemical Biology (Ministry of Education), Department of Pharmaceutics, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, PR China. Electronic address: .
Pokaż więcej
Źródło:
European journal of medicinal chemistry [Eur J Med Chem] 2024 Jan 05; Vol. 263, pp. 115952. Date of Electronic Publication: 2023 Nov 16.
Typ publikacji:
Journal Article
MeSH Terms:
Doxorubicin*/pharmacology
Autophagy*
Cell Line, Tumor ; Immunity
Czasopismo naukowe
Tytuł:
Assessment of early anthracycline-induced cardiotoxicity and liver injury with T2 and T2* mapping in rabbit models.
Autorzy:
Feng XL; Department of Radiology, The Affiliated Hospital of Southwest Medical University, 25# Tai Ping Street, Luzhou, 646000, Sichuan, China.
Qi WY; Department of Radiology, The Affiliated Hospital of Southwest Medical University, 25# Tai Ping Street, Luzhou, 646000, Sichuan, China.
Xiao ZY; Department of Radiology, The Affiliated Hospital of Southwest Medical University, 25# Tai Ping Street, Luzhou, 646000, Sichuan, China.
Zheng X; Department of Radiology, The Affiliated Hospital of Southwest Medical University, 25# Tai Ping Street, Luzhou, 646000, Sichuan, China.
Zhang XY; Department of Clinical Science, Philips Healthcare, Chengdu, 610000, China.
Liu T; Department of Radiology, The Affiliated Hospital of Southwest Medical University, 25# Tai Ping Street, Luzhou, 646000, Sichuan, China.
Kou XY; Department of Radiology, The Affiliated Hospital of Southwest Medical University, 25# Tai Ping Street, Luzhou, 646000, Sichuan, China.
Chen J; Department of Radiology, The Affiliated Hospital of Southwest Medical University, 25# Tai Ping Street, Luzhou, 646000, Sichuan, China. .
Pokaż więcej
Źródło:
European radiology [Eur Radiol] 2024 Jan; Vol. 34 (1), pp. 226-235. Date of Electronic Publication: 2023 Aug 08.
Typ publikacji:
Journal Article
MeSH Terms:
Anthracyclines*/adverse effects
Antibiotics, Antineoplastic*/adverse effects
Cardiotoxicity*/diagnostic imaging
Cardiotoxicity*/drug therapy
Doxorubicin*/therapeutic use
Animals ; Rabbits ; Iron ; Liver/diagnostic imaging
Czasopismo naukowe
Tytuł:
The effects of doxorubicin loaded aptamer S3-linked DNA tetrahedrons on nasopharyngeal carcinoma.
Autorzy:
Liu X; NHC Key Laboratory of Carcinogenesis, Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.; Cancer Research Institute, School of Basic Medical Science, Central South University, Changsha, Hunan, 410078, China.
Jiang B; Cancer Research Institute of Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China.
Cheng A; Cancer Research Institute of Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China.
Guo Y; NHC Key Laboratory of Carcinogenesis, Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.; Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.
Wang L; NHC Key Laboratory of Carcinogenesis, Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.; Cancer Research Institute, School of Basic Medical Science, Central South University, Changsha, Hunan, 410078, China.
Liu W; NHC Key Laboratory of Carcinogenesis, Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.; Cancer Research Institute, School of Basic Medical Science, Central South University, Changsha, Hunan, 410078, China.
Yin W; NHC Key Laboratory of Carcinogenesis, Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.; Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.
Li Y; NHC Key Laboratory of Carcinogenesis, Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.; Cancer Research Institute, School of Basic Medical Science, Central South University, Changsha, Hunan, 410078, China.
Jiang X; NHC Key Laboratory of Carcinogenesis, Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China. .; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China. .; Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China. .
Ren C; NHC Key Laboratory of Carcinogenesis, Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China. .; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China. .; Cancer Research Institute, School of Basic Medical Science, Central South University, Changsha, Hunan, 410078, China. .
Pokaż więcej
Źródło:
Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale [J Otolaryngol Head Neck Surg] 2023 Dec 12; Vol. 52 (1), pp. 79. Date of Electronic Publication: 2023 Dec 12.
Typ publikacji:
Journal Article
MeSH Terms:
Doxorubicin*/pharmacology
Doxorubicin*/therapeutic use
Nasopharyngeal Neoplasms*/drug therapy
Animals ; Mice ; Nasopharyngeal Carcinoma/drug therapy ; Mice, Nude ; Cell Line, Tumor ; DNA
Czasopismo naukowe
Tytuł:
B7H3 targeting gold nanocage pH-sensitive conjugates for precise and synergistic chemo-photothermal therapy against NSCLC.
Autorzy:
Chen B; Key Laboratory of Nanomedical Technology (Education Department of Fujian Province), School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China.; Department of Pharmaceutical Analysis, School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China.
Zheng K; Key Laboratory of Nanomedical Technology (Education Department of Fujian Province), School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China.; Department of Pharmaceutical Analysis, School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China.
Fang S; The Cancer Center, Union Hospital, Fujian Medical University, Fuzhou, 350122, China.
Huang K; Key Laboratory of Nanomedical Technology (Education Department of Fujian Province), School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China.
Chu C; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen, 361102, China.
Zhuang J; Key Laboratory of Nanomedical Technology (Education Department of Fujian Province), School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China.; Department of Pharmaceutical Analysis, School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China.
Lin J; Department of Pharmaceutical Analysis, School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China.
Li S; Key Laboratory of Nanomedical Technology (Education Department of Fujian Province), School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China.; Department of Pharmaceutical Analysis, School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China.
Yao H; Key Laboratory of Nanomedical Technology (Education Department of Fujian Province), School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China.; Department of Pharmaceutical Analysis, School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China.
Liu A; Key Laboratory of Nanomedical Technology (Education Department of Fujian Province), School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China.; Department of Pharmaceutical Analysis, School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China.
Liu G; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen, 361102, China. .
Lin J; The Cancer Center, Union Hospital, Fujian Medical University, Fuzhou, 350122, China. .; The Department of Otolaryngology, Head and Neck Surgery, University of Minnesota Medical School, Minneapolis, 55404, USA. .
Lin X; Key Laboratory of Nanomedical Technology (Education Department of Fujian Province), School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China. .; Department of Pharmaceutical Analysis, School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China. .
Pokaż więcej
Źródło:
Journal of nanobiotechnology [J Nanobiotechnology] 2023 Oct 17; Vol. 21 (1), pp. 378. Date of Electronic Publication: 2023 Oct 17.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Doxorubicin*/pharmacology
Doxorubicin*/therapeutic use
Lung Neoplasms*/drug therapy
Nanoparticles*
Photothermal Therapy*/methods
Antineoplastic Agents*/pharmacology
Antineoplastic Agents*/therapeutic use
Humans ; B7 Antigens ; Cell Line, Tumor ; Drug Liberation ; Gold ; Hydrogen-Ion Concentration ; Hyperthermia, Induced ; Phototherapy ; Tumor Microenvironment ; Animals ; Mice ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł:
Amplified Targeted Drug Delivery Independent of Target Number through Alternative Administration of Two Matched Nanoparticles.
Autorzy:
Song M; School of Pharmaceutical Sciences, University of South China, Hengyang 421001, China.; Department of Neurology, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang 42100, Hunan, China.; Beijing Institute of Basic Medical Sciences, No. 27 Taiping Road, Haidian District, Beijing 100850, China.
Cao R; National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
Chen X; National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.; Institute of Medical Research, Northwestern Polythechnical University, Xi'an 710072, China.
Wang C; Beijing Institute of Basic Medical Sciences, No. 27 Taiping Road, Haidian District, Beijing 100850, China.
Xing X; Beijing Institute of Basic Medical Sciences, No. 27 Taiping Road, Haidian District, Beijing 100850, China.
Li W; National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
Li Y; National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
Liao Y; School of Pharmaceutical Sciences, University of South China, Hengyang 421001, China.; Department of Neurology, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang 42100, Hunan, China.; Beijing Institute of Basic Medical Sciences, No. 27 Taiping Road, Haidian District, Beijing 100850, China.
Zhong W; National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
Li Q; Department of Stomatology, the Fifth Medical Center, Chinese PLA General Hospital, 8 East Street, Fengtai District, Beijing 100071, China.
Liu Z; School of Pharmaceutical Sciences, University of South China, Hengyang 421001, China.; Department of Neurology, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang 42100, Hunan, China.; Beijing Institute of Basic Medical Sciences, No. 27 Taiping Road, Haidian District, Beijing 100850, China.
Pokaż więcej
Źródło:
ACS nano [ACS Nano] 2023 Dec 12; Vol. 17 (23), pp. 23359-23373. Date of Electronic Publication: 2023 Dec 01.
Typ publikacji:
Journal Article
MeSH Terms:
Doxorubicin*/chemistry
Nanoparticles*/chemistry
Drug Delivery Systems/methods ; Cell Line, Tumor
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies